Results 21 to 30 of about 20,292 (247)
Risk of earlier atherosclerotic cardiovascular disease in women with low bone mineral density
Scientific Reports, 2022 Low bone mineral density (BMD) is associated with higher risk of atherosclerotic cardiovascular disease (ASCVD) in women. We investigated whether the association between low BMD and ASCVD differs according to the age at ASCVD occurrence.
Jiesuck Park +4 more
doaj +1 more source
, 2023 Statins are comprehensive lipid-lowering agents, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. As an effective cholesterol-lowering drug, statins inhibit a key step in the cholesterol biosynthesis pathway and have made outstanding contributions to the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD ...
Cong Lu +4 more
openaire +1 more source
ASCVD risk estimates’ association with categorical participant characteristics.
, 2023 ASCVD risk estimates’ association with categorical participant characteristics.
Salim S. Virani (6107183) +3 more
core +1 more source
Diabetology & Metabolic Syndrome, 2021 Background Atherosclerosis cardiovascular disease (ASCVD) is the main cause of morbidity and mortality in type 2 diabetes mellitus (T2DM). As most diabetic patients with ASCVD are asymptomatic, it is most neglected in clinical practice.
Lu Gao +3 more
doaj +1 more source
Association of hyperuricemia combined with sarcopenia on ASCVD risk
BMC Cardiovascular Disorders, 2023 Abstract Background Hyperuricemia and sarcopenia are both strongly linked to an increased risk of atherosclerotic cardiovascular disease (ASCVD), and this study was designed to look into the interactive effects of hyperuricemia on ASCVD risk.
Guqiao Nie +5 more
openaire +3 more sources
ASCVD risk assessment and comparison between different cohorts.
, 2022 ASCVD risk assessment and comparison between different cohorts.
Vineetha Menon (12969366) +5 more
core +1 more source
American Journal of Preventive Cardiology, 2022 Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity both in generally healthy persons and in those with known ASCVD.
Nathan D. Wong +7 more
doaj +1 more source
American Journal of Preventive Cardiology, 2023 Objective: Assess discrepancy between estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk and observed 10-year event rates in a rural population participating in cardiovascular health initiative.
Christopher Van Hove +7 more
doaj +1 more source
Physicians’ knowledge about ASCVD risk assessment before statin therapy initiation.
, 2022 Physicians’ knowledge about ASCVD risk assessment before statin therapy initiation.
Abdulsalam Halboup (11575362) +4 more
core +1 more source
Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity
Respiratory Research, 2022 Background Sarcopenia is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD), but its relationship with chronic obstructive pulmonary disease (COPD) has not been fully determined.
Ah Young Leem +6 more
doaj +1 more source